Now showing items 9-12 of 20

    • Thumbnail

      Epigenetika helburu duten sendagaiak 

      Martínez Peula, Oihane; Rivero Calera, Guadalupe ORCID (Servicio Editorial de la Universidad del País Vasco/Euskal Herriko Unibertsitatearen Argitalpen Zerbitzua, 2021)
      “Epigenetics” refers to any change in genetic activity without altering DNA sequence. Non-genetic factors (i.e. infections and drugs) may cause epigenetic alterations throughout our genome, indicating which gene will be ...
    • Thumbnail

      Minbiziaren aurkako CAR-T zelulen bidezko immunoterapia 

      García Gallastegui, Patricia ORCID; Mugica Basauri, Maite; Crende Arruabarrena, Olatz (Servicio Editorial de la Universidad del País Vasco/Euskal Herriko Unibertsitatearen Argitalpen Zerbitzua, 2021)
      The last years immunotherapy has become a useful strategy in the fight against cancer. One of the most popular therapies is called CAR-T. In this treatment, the patient’s T lymphocytes are removed and modified in the ...
    • Thumbnail

      Misio kritikorako MCPTT zerbitzuaren integrazioa 5G-NFV ertzeko konexio-sare batean 

      López Cuadrado, Javier ORCID; Blanco Jauregui, Begoña; Jimeno, Elisa; Catalán Cid, Miguel; Atxutegi Narbona, Eneko ORCID (Servicio Editorial de la Universidad del País Vasco/Euskal Herriko Unibertsitatearen Argitalpen Zerbitzua, 2021)
      5G teknologiaren helburu handienetako bat da egungo komunikazio-ekosistema hobetzea. Helburu hori lortzeko, etorkizun handiko irtenbidea da ertzeko konexio-sareen erabilpena, batez ere misio kritikoko zerbitzuak erabiltzen ...
    • Thumbnail

      Meduloblastoma pediatrikoaren pronostikorako markatzaile molekularren identifikazioa 

      Frutos Gallastegui, Begoña; López López, Elixabet ORCID; Illarregi, Unai; Bilbao Aldaiturriaga, Nerea; García Ariza, Miguel Angel; Gutiérrez Camino, Ángela ORCID; Martín Guerrero, Idoia (Servicio Editorial de la Universidad del País Vasco/Euskal Herriko Unibertsitatearen Argitalpen Zerbitzua, 2021)
      Medulloblastoma is a very heterogeneous malignancy at both clinical and molecular levels. In recent years, thanks to the development of massive and whole genome sequencing techniques, many specific mutations have been ...